Pulmonology Clinical Trials

Join COPD Clinical Trials in Oklahoma City, OK, and help improve outcomes for those with Chronic Obstructive Pulmonary Disease (COPD). Hightower is recruiting participants for a study evaluating a new triple therapy aimed at reducing cardiopulmonary risks in COPD patients. The trial compares this innovative treatment to standard dual therapy to identify better outcomes. Participation is free, and all study-related care is provided at no cost. Eligible individuals, aged 40-80, can contribute to this important research and potentially improve their quality of life while receiving expert care. Fill out the form to determine your eligibility.

Severe Eosinophilic Asthma is a debilitating respiratory condition marked by persistent airway inflammation due to elevated eosinophil levels. It affects 5-10% of asthma patients and is resistant to standard treatments.

Hightower Clinicals is investigating a novel drug to target its mechanisms. This innovative research offers hope for better management and symptom alleviation, potentially transforming the lives of those affected.

Hightower aims to address the unmet medical needs of severe eosinophilic asthma patients, providing a promising avenue for improved treatment outcomes and enhanced quality of life.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.*